Swiss National Bank
TMCI icon

Swiss National Bank’s Treace Medical Concepts TMCI Stock Holding History

Swiss National Bank’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-84,700
Closed -$491K – 2476
2024
Q3 		$491K Sell
84,700
-6,200
-7% -$39.8K ﹤0.01% 2435
2024
Q2 		$604K Hold
90,900
– – ﹤0.01% 2375
2024
Q1 		$1.19M Hold
90,900
– – ﹤0.01% 2130
2023
Q4 		$1.16M Sell
90,900
-10,200
-10% -$103K ﹤0.01% 2159
2023
Q3 		$1.33M Buy
101,100
+14,300
+16% +$262K ﹤0.01% 2085
2023
Q2 		$2.22M Buy
86,800
+50,800
+141% +$1.31M ﹤0.01% 1819
2023
Q1 		$907K Sell
36,000
-4,100
-10% -$96.3K ﹤0.01% 2309
2022
Q4 		$922K Buy
40,100
+800
+2% +$18.4K ﹤0.01% 2386
2022
Q3 		$867K Buy
39,300
+1,600
+4% +$31K ﹤0.01% 2402
2022
Q2 		$541K Hold
37,700
– – ﹤0.01% 2593
2022
Q1 		$713K Buy
37,700
+2,900
+8% +$56.4K ﹤0.01% 2519
2021
Q4 		$649K Buy
+34,800
New +$718K ﹤0.01% 2604

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Swiss National Bank's TMCI Position: Q4 2024 in Review

Swiss National Bank sold out of Treace Medical Concepts (TMCI) in Q4 2024, closing a stake of 84,700 shares — an estimated $491K sold.

Swiss National Bank first reported a position in TMCI in Q4 2021 and held it in 12 quarters. The position peaked at $2.22M in Q2 2023. 135 funds tracked by Wall St. Rank hold TMCI as of Q4 2024.

  • Swiss National Bank reported no remaining Treace Medical Concepts position as of Q4 2024 after selling out during the quarter.
  • Swiss National Bank sold 84,700 Treace Medical Concepts shares in Q4 2024, an estimated $491K.
  • Swiss National Bank first reported a position in Treace Medical Concepts in Q4 2021 and held it in 12 quarters.
  • Swiss National Bank's Treace Medical Concepts position peaked at $2.22M in Q2 2023.
  • 135 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2024.

Based on Swiss National Bank's 13F filing for Q4 2024, filed 10 Feb 2025.